18F-Labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques
作者:Pingrong Yu、Mengchao Cui、Xuedan Wang、Xiaojun Zhang、Zijing Li、Yanping Yang、Jianhua Jia、Jinming Zhang、Masahiro Ono、Hideo Saji、Hongmei Jia、Boli Liu
DOI:10.1016/j.ejmech.2012.08.031
日期:2012.11
In continuation of our study on the 2-phenylquinoxaline scaffold as potential beta-amyloid imaging probes, two [F-18]fluoro-pegylated 2-phenylquinoxaline derivatives, 2-(4-(2-[F-18]fluoroethoxy)phenyl)-N-methylquinoxalin-6-amine ([F-18]4a) and 2-(4-(2-(2-(2-[F-18]fluoroethoxy)ethoxy)ethoxy)phenyl)-N-methylquinoxalin-6-amine ([F-18]4b) were prepared. Both of them displayed high binding affinity to A beta(1-42) aggregates (K-i = 10.0 +/- 1.4 nM for 4a, K-i = 5.3 +/- 3.2 nM for 4b). The specific and high binding of [F-18]4a and [F-18]4b to A beta plaques was confirmed by in vitro autoradiography on brain sections of AD human and transgenic mice. In biodistribution in normal mice, [F-18]4a displayed high initial brain uptake (8.17% ID/g at 2 min) and rapid washout from the brain. These preliminary results suggest [F-18]4a may be a potential PET imaging agent for AI plaques in the living human brain. (C) 2012 Elsevier Masson SAS. All rights reserved.